Investors > As an investment
Revenio is a health tech group operating on the international market and a global leader in ophthalmological devices. Revenio Group's ophthalmic diagnostic solutions include intraocular pressure measurement devices under the iCare brand, retinal imaging devices and perimeters. The main tools for the detection and diagnosis of glaucoma and its monitoring during treatment are intraocular pressure measurement (tonometry), retinal imaging, and visual field tests (perimetry).
We use Finnish technology to improve the life expectancy and quality of life of people around the world. Health care megatrends, such as aging populations and a global need for cost savings, support our growth targets.
We have strong evidence of the growth of net sales and our good level of profitability. We have an excellent operating profit margin.
More than half of our share capital is owned by private investors and briskly traded. We always seek to remember our owners and have a history of good dividend payment performance.
Knowledge of the industry and global markets
World-class quality products and processes
Research and development
Steady cash flow from sensor sales
Utilizing IP-protected Finnish inventions
Profitability and balance sheet
Chronic diseases become more common
Infrastructures are incapable of treating the required numbers of patients